- Home
- CLLS vs PAII Comparison
CLLS vs PAII Comparison
Compare CLLS & PAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- PAII
- Stock Information
- Founded
- CLLS 1999
- PAII 2025
- Country
- CLLS France
- PAII United States
- Employees
- CLLS N/A
- PAII N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- PAII
- Sector
- CLLS Health Care
- PAII
- Exchange
- CLLS Nasdaq
- PAII Nasdaq
- Market Cap
- CLLS 299.0M
- PAII 271.3M
- IPO Year
- CLLS 2007
- PAII 2025
- Fundamental
- Price
- CLLS $3.79
- PAII $9.95
- Analyst Decision
- CLLS Buy
- PAII
- Analyst Count
- CLLS 1
- PAII 0
- Target Price
- CLLS $4.00
- PAII N/A
- AVG Volume (30 Days)
- CLLS 151.7K
- PAII 229.1K
- Earning Date
- CLLS 11-03-2025
- PAII 01-01-0001
- Dividend Yield
- CLLS N/A
- PAII N/A
- EPS Growth
- CLLS N/A
- PAII N/A
- EPS
- CLLS N/A
- PAII N/A
- Revenue
- CLLS $63,438,000.00
- PAII N/A
- Revenue This Year
- CLLS N/A
- PAII N/A
- Revenue Next Year
- CLLS $66.76
- PAII N/A
- P/E Ratio
- CLLS N/A
- PAII N/A
- Revenue Growth
- CLLS 223.09
- PAII N/A
- 52 Week Low
- CLLS $1.10
- PAII $9.92
- 52 Week High
- CLLS $3.83
- PAII $9.97
- Technical
- Relative Strength Index (RSI)
- CLLS 65.98
- PAII N/A
- Support Level
- CLLS $3.36
- PAII N/A
- Resistance Level
- CLLS $3.60
- PAII N/A
- Average True Range (ATR)
- CLLS 0.24
- PAII 0.00
- MACD
- CLLS 0.02
- PAII 0.00
- Stochastic Oscillator
- CLLS 96.95
- PAII 0.00
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About PAII Pyrophyte Acquisition Corp. II Class A Ordinary Shares
Pyrophyte Acquisition Corp II is a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.